# Züri Can Extended By Two Years As Results Point To Black Market Deterrence > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/2026-cannabis-black-market-deterrence-zuri-can-extension/ > **Published:** 2026-04-02T17:04:57-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:31:45-04:00 > **Clinical Summary:** The 2026 cannabis black market deterrence is highlighted by the Züri Can pilot extension, showing benefits of regulated cannabis access and product quality. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic RegulationProduct Quality[Public Health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/)InternationalPolicy Why This Matters The Züri Can pilot program provides real-world evidence on regulated cannabis access models that could inform clinical practice frameworks. Understanding how regulated distribution affects patient behavior and product quality helps clinicians better counsel patients navigating legal vs. illicit markets. Clinical Summary Zürich’s Züri Can pilot program, which allows regulated cannabis sales to adults, has been extended by two years based on preliminary findings suggesting reduced black market activity. The program provides controlled access to tested cannabis products through licensed dispensaries. Early data indicates participants are accessing regulated products instead of illicit alternatives, though comprehensive clinical outcomes data remains limited. Dr. Caplan’s Take “What matters clinically is that patients are getting tested, consistent products rather than unknown street cannabis. This pilot gives us a glimpse of how medical-grade quality control might extend beyond traditional medical programs.” Clinical Perspective 🧠 For clinicians, this reinforces the importance of product quality and consistency in patient outcomes. Patients in regions with regulated access should be counseled about the clinical advantages of tested products with known cannabinoid profiles over illicit alternatives. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Z%C3%BCri%20Can%20Extended%20By%20Two%20Years%20As%20Results%20Point%20To%20Black%20Market%20Deterrence%20%40drcaplan&url=https%3A//businessofcannabis.com/zuri-can-extended-by-two-years-as-results-point-to-black-market-deterrence/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//businessofcannabis.com/zuri-can-extended-by-two-years-as-results-point-to-black-market-deterrence/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Z%C3%BCri%20Can%20Extended%20By%20Two%20Years%20As%20Results%20Point%20To%20Black%20Market%20Deterrence%20--%20via%20%40drcaplan.bsky.social%20https%3A//businessofcannabis.com/zuri-can-extended-by-two-years-as-results-point-to-black-market-deterrence/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://businessofcannabis.com/zuri-can-extended-by-two-years-as-results-point-to-black-market-deterrence/](https://businessofcannabis.com/zuri-can-extended-by-two-years-as-results-point-to-black-market-deterrence/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What key areas does this cannabis news cover?](#What_key_areas_does_this_cannabis_news_cover) - [Why is this classified as emerging information?](#Why_is_this_classified_as_emerging_information) - [How does this relate to clinical cannabis practice?](#How_does_this_relate_to_clinical_cannabis_practice) - [What makes this internationally significant?](#What_makes_this_internationally_significant) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely. #### What key areas does this cannabis news cover? The article focuses on four main areas: regulation, product quality, public health, and international developments. These topics are particularly relevant for clinicians working with [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/). #### Why is this classified as emerging information? The content is marked as “New” and categorized under emerging findings worth monitoring. This indicates recent developments in cannabis policy or research that could impact clinical practice. #### How does this relate to clinical cannabis practice? As a CED Clinic cannabis news item with notable clinical interest, this information is relevant for healthcare providers prescribing or considering cannabis treatments. The regulatory and product quality aspects are particularly important for patient safety. #### What makes this internationally significant? The international tag suggests this news covers cross-border cannabis developments or policies. This could include changes in international regulations, research collaborations, or global trends affecting [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Z\u00fcri Can Extended By Two Years As Results Point To Black Market Deterrence”, “url”: “https://businessofcannabis.com/zuri-can-extended-by-two-years-as-results-point-to-black-market-deterrence/”, “datePublished”: “2026-04-02T17:53:19Z”, “about”: “z ri can extended two years”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [First year of Dutch cannabis pilot project a success | StratCann](https://cedclinic.com/dutch-cannabis-pilot-project-success-first-year/) Explore insights from the Dutch cannabis pilot project, highlighting successes in regulated cannabis access and market impacts. [Read More](https://cedclinic.com/dutch-cannabis-pilot-project-success-first-year/) [California Marks 10 Years Of Cannabis Legalization Amid Illegal Market Struggle – Forbes](https://cedclinic.com/california-cannabis-legalization-10-years-market-safety/) Review California's decade-long [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) journey and its ongoing challenges with the illegal market. [Learn More](https://cedclinic.com/california-cannabis-legalization-10-years-market-safety/) [Opinion: What cannabis legalization looks like in New York today](https://cedclinic.com/new-york-cannabis-legalization-implementation/) Understand the current landscape of [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) in New York and its effects on regulated and illicit markets. [Explore Now](https://cedclinic.com/new-york-cannabis-legalization-implementation/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).